European Investment Bank’s Investment in Cape Bio Pharms’ Operations for EUR 33.3 million

Lead party: European Investment Bank (EIB) (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Cape Bio Pharms Transaction type: Debt Financing · Asset class: Venture Capital · Strategy: Direct Lending · Instrument: Term Loan · Deal amount: US$40.7m Lead investor/buyer: European Investment Bank (EIB) · Investors/buyers: European Investment…


Lead party: European Investment Bank (EIB) (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Cape Bio Pharms

Transaction type: Debt Financing · Asset class: Venture Capital · Strategy: Direct Lending · Instrument: Term Loan · Deal amount: US$40.7m

Lead investor/buyer: European Investment Bank (EIB) · Investors/buyers: European Investment Bank (EIB)

Legal advisers: not identified in the source record.

Source: announced 18 December 2020. Original announcement: businessinsider.co.za.